Checkpoint inhibitor (CPI) experienced patients (pts) from COSMUS-1: A clinical observational study of talimogene laherparepvec (T-VEC) in United States practice Meeting Abstract
| Authors: | Perez, M.; Amatruda, T.; Conry, R. M.; Ariyan, C. E.; Desai, A. M.; Kirkwood, J. M.; Treichel, S.; Ismail, R.; Raskin, L. |
| Abstract Title: | Checkpoint inhibitor (CPI) experienced patients (pts) from COSMUS-1: A clinical observational study of talimogene laherparepvec (T-VEC) in United States practice |
| Meeting Title: | 2019 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2019 Feb 28-Mar 2 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-10 |
| Language: | English |
| ACCESSION: | WOS:000489109600145 |
| DOI: | 10.1200/JCO.2019.37.8_suppl.142 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 142 -- Source: Wos |
